1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ANO10 CTRPv2 pan-cancer AAC -0.13 0.0007
mRNA SNX15 CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA TWSG1 CTRPv2 pan-cancer AAC -0.13 0.0007
mRNA SHCBP1 CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA RP11-382A20.3 CTRPv2 pan-cancer AAC -0.13 0.0007
mRNA SIRPA CTRPv2 pan-cancer AAC 0.14 0.0007
mRNA C1QTNF8 CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA TBL1X CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA ERCC2 CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA C5orf47 CTRPv2 pan-cancer AAC 0.12 0.0007
Download CSV